EIQ.AX is trading 30.2% up today at A$1.61 after announcing a major funding and distribution agreement with Pro Medicus to accelerate its U.S. market expansion.
- The deal provides Echo IQ with access to up to A$20 million in secured convertible notes and debt funding, significantly strengthening its balance sheet for future growth.
- Pro Medicus will serve as a U.S. commercial partner to resell the EchoSolv software, providing critical support for regulatory submissions and American market penetration.
- The surge reflects investor confidence in the strategic backing and the clearer commercialization path for the company's cardiac diagnostic technology.